Our mission is to serve as the catalyst for vision research, and our
highest priority is to foster interactive, interdisciplinary, and translational
studies of how the visual system functions in health and disease.


| 2017 | 2016 | 2015 | 2014 | 2013 | Earlier | NEWSLETTERS | 


American Academy of Ophthalmology Award
December 2, 2013

Dr. Daniel Albert, Founding Director of the McPherson ERI, received the prestigious Laureate Recognition Award from the American Academy of Ophthalmology (AAO), the highest honor given by the Academy. The award to Dr. Albert was presented on Sunday, November 17, 2013, during the Opening Session of during the opening session of the AAO annual meeting in New Orleans, LA. The Laureate Award recognizes an ophthalmologist who has made extraordinary scientific contributions toward preventing blindness and restoring sight worldwide. In celebration of the AAO Award, and of the full establishment of the Retina Research Foundation/Daniel M. Albert Chair, the McPherson ERI and the Department of Ophthalmology co-hosted a lecture and reception in honor of Dr. Albert and Dr. Carmen A. Puliafito, Dean of the Keck School of Medicine at USC, gave a wide-ranging talk about his Adventures in Eye Research and his longstanding relationship with Dr. Albert.


Bikash Pattnaik Funded for Pediatric Blindness Research
Summer, 2013

Dr. Bikash Pattnaik, PhD, McPherson ERI member and past holder of the RRF Rebecca Meyer Brown Professorship, has received a $1 million-plus gift for the study of novel therapy approaches for Leber Congenital Amaurosis (LCA). In collaboration with Co-Investigators David Gamm, MD, PhD, and William Hauswirth, PhD (University of Florida), Dr. Pattnaik's three-year study aims, among other things, to overcome defects in potassium channel functioning in genes with the LCA16 mutation.

Advancing Therapy for LCA16 in Dr. Pattnaik's Lab


Dietary Supplements: Do They Help with AMD?
May, 2013

Drs. Barbara Blodi, Ronald Danis, and Suresh Chandra are among the authors of the long-awaited AREDS2 study, which examined the effect of various dietary supplements (including omega-3 fatty acids, lutein and zeaxanthin) in subjects with age-related macular degeneration. UW Health Drs. Justin Gottlieb, Michael Ip, Michael Altaweel, and Thomas Stevens also followed patients for the study.C ontact Dr. Blodi at bablodi@wisc.edu if you have questions about AREDS2.

National Eye Institute Press Release
AREDS2 Study Published Results


Finding New Treatments for AMD
March, 2013

Dr. Nader Sheibani and colleagues at UW-Madison (including co-investigators Dr. Christine Sorenson and Dr. Bikash Pattnaik, Dr. Ronald Danis, and Dr. Daniel Albert), Northwestern University and the University of Nebraska Medical Center were recently awarded a $6.2 million grant over five years from the National Eye Institute to study new treatments for wet AMD.

Quest for New Macular Degeneration Therapy in Dr. Sheibani's Lab